Dyadic International, Inc. (NASDAQ: DYAI), operating as Dyadic Applied BioSolutions, has entered into definitive agreements with an institutional investor for a registered direct offering of 3,625,000 common shares and a concurrent private placement of warrants to purchase an equal number of common shares. The common shares are priced at $0.795 each, with warrants priced at $0.005 each and an exercise price of $0.84 per share. Aggregate gross proceeds are expected to be approximately $2.9 million, with the transactions expected to close on or about Aug. 14, 2026, subject to customary closing conditions.
The company intends to use the net proceeds, along with existing cash, cash equivalents, restricted cash, and investment-grade securities, for working capital and general corporate purposes. Aegis Capital Corp. is serving as exclusive placement agent for the offerings. This capital infusion arrives at a pivotal time for Dyadic, which is focused on developing and commercializing scalable, non-animal protein production platforms to address growing global demand across life sciences, food and nutrition, and bio-industrial markets.
Dyadic's proprietary Dapibus™ and C1 expression systems are designed to enable rapid, cost-effective, and flexible manufacturing of high-value proteins. These technologies aim to help customers develop more efficient, scalable, and sustainable products. The funding is expected to support ongoing research and development, as well as commercialization efforts, potentially accelerating the adoption of Dyadic's alternatives to traditional animal-derived proteins.
The significance of this offering extends beyond the immediate capital. It signals continued investor interest in biotechnology companies that address sustainability challenges. Dyadic's focus on non-animal proteins aligns with broader trends toward plant-based and fermentation-derived ingredients in food, nutrition, and industrial applications. By strengthening its balance sheet, Dyadic is better positioned to pursue strategic partnerships and expand its product pipeline.
According to the press release, the full details of the offering are available at https://ibn.fm/od7FJ. For more information about Dyadic International, visit https://dyadic.com/.
